GLP-1 BMI Requirements 2026: Who Actually Qualifies?

"Do I qualify?" is the single most-asked GLP-1 question. The answer depends on three different gates — the FDA's, your insurance plan's, and the clinic's. In 2026, they don't always agree.

The FDA gate (applies to brand-name only)

The FDA-approved indications for weight management:

"Weight-related condition" means hypertension, type 2 diabetes, dyslipidemia, obstructive sleep apnea, or cardiovascular disease.

If you're under 27 BMI with no comorbidities, the on-label answer is no.

The insurance gate (often stricter than FDA)

This is where it gets specific. Even on FDA-approved indications, many plans add their own hurdles:

• BMI ≥ 30 plus 6 months of documented diet/exercise ("step therapy")
• BMI ≥ 35 (some employer plans tightened in 2025–2026)
• Lower-cost plan tiers may exclude obesity drugs entirely
• Medicare Part D historically excluded weight-loss drugs; 2025–2026 has seen partial expansion for cardiovascular indications

Always call the number on your card and ask for the coverage criteria in writing. Full insurance/PA guide →

The clinic gate (the most lenient)

Telehealth clinics generally mirror the FDA criteria but can be a bit more flexible for cash-pay:

• Most clinics: BMI ≥ 27 with a comorbidity, or ≥ 30 without
• Aesthetic / cash-pay-only: occasionally BMI ≥ 25 with a justifying condition. Be cautious — clinics that approve at BMI < 27 without any condition are operating outside conventional clinical guidelines.

Compounded semaglutide and tirzepatide are not technically "FDA-approved for weight loss," so clinics applying their own criteria varies more.

Common exceptions that get borderline patients approved

A "borderline" patient (BMI 27–30) without an obvious comorbidity can sometimes qualify by documenting:

• Prediabetes (A1C 5.7–6.4)
• Hypertension — even controlled on medication
• Dyslipidemia — high LDL, low HDL, or high triglycerides
• PCOS — increasingly accepted as a metabolic comorbidity
• NAFLD / fatty liver confirmed on imaging or labs
• Sleep apnea with a sleep-study diagnosis

If you suspect any of these but don't have a diagnosis, getting basic labs first can change your eligibility.

When you definitely don't qualify

Clear contraindications — most clinics will decline regardless of BMI:

• Personal or family history of medullary thyroid carcinoma
• History of MEN 2 syndrome
• History of pancreatitis
• Current pregnancy or breastfeeding
• Severe gastroparesis or other major GI motility disorders
• Type 1 diabetes (with caveats)

What to do if you're under threshold

If your BMI is below 27 with no comorbidities, the honest path is not a GLP-1 — clinical guidelines weren't written for you, and side-effect risk in lean patients isn't well studied. Behavioral and dietary interventions remain the first line.

If you're close (BMI 26–27) it's worth asking your primary-care doctor for a metabolic workup. A documented comorbidity may legitimately open the door.

Ready to check eligibility?

Find a clinic → — most clinics on TrimSoMo do a free pre-screening before any payment. Filter by state and Trust Score.

General information, not medical advice. Eligibility decisions are made by a licensed clinician reviewing your full history. BMI is one input, not the only one.